A study by Pavia et al. indicated that overexpression of APOC3 results in pathological features in the liver similar to NAFLD such as inflammation, hepatocyte apoptosis, oxidative stress, and increased liver lipid content [107]. Here, APOC3 is linked to metabolic dysfunction-associated steatotic liver disease.